Continuous monitoring device with advanced features and analytics to deliver personalized insights directly to the smartphone REDWOOD CITY, Calif.–(BUSINESS WIRE)–Biotricity, Inc. (NASDAQ:BTCY), a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions, today announced the availability of Bioheart, a direct-to-consumer heart monitor that offers the same continuous heart monitoring technology […]
Rhythm
New Norwegian heart sensor better than today’s hospital equipment to detect atrial fibrillation
LILLESAND, Norway, Nov. 10, 2021 /PRNewswire/ — The innovative heart sensor ECG247, which has been developed and manufactured by Appsens AS in Norway, is shown to be better than the equipment most of the world’s hospitals and heart specialists use to find heart rhythm disorders, according to a new study published in the renowned […]
Vektor Medical Receives FDA Clearance for vMap™, First Technology Designed to Identify Arrhythmia Hot Spots Anywhere in Heart in Minutes Using Only ECG Data
Non-Invasive Technology Requires No Vests, CT or MRI Imaging, or Invasive Mapping SAN DIEGO–(BUSINESS WIRE)–Vektor Medical, Inc. today announced U.S. Food and Drug Administration (FDA) 510(k) clearance for its novel computational ECG mapping system, vMap™. vMap is designed to map potential arrhythmia sources (hot spots) associated with stable or unstable […]
ScanWatch – The Most Advanced Hybrid Smartwatch from Withings Becomes Commercially Available Across America
ScanWatch, which received FDA clearance for atrial fibrillation detection through ECG and measuring SpO2 levels from the wrist, becomes available in the United States ISSY-LES-MOULINEAUX, France, Nov. 9, 2021 /PRNewswire/ — Today, Withings, pioneers of the connected health revolution, begins U.S. sales of ScanWatch, its award-winning and most advanced health wearable to date. Available from […]
BioSig Installs its Signal Processing Technology for Arrhythmia Care at a Leading Hospital in Boston
Latest installation follows a steady rise in patient cases conducted with the PURE EP™ System Westport, CT, Nov. 08, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the […]
Alnylam Initiates KARDIA-2 Phase 2 Study of Investigational Zilebesiran (ALN-AGT) in Patients with Inadequately Controlled Hypertension
– KARDIA-2 will Evaluate Efficacy and Safety of Zilebesiran when Used in Combination with Conventional Antihypertensive Medications – CAMBRIDGE, Mass.–(BUSINESS WIRE)–Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced initiation of KARDIA-2, a global Phase 2 study to evaluate the efficacy and safety of zilebesiran (formerly known as […]
BioSig Expands its Installation Base in Texas
Signs a new installation agreement with high-volume center in San Antonio Westport, CT, Nov. 04, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG […]
Peerbridge Health and BetterNight partnership addresses unmet need in AFib and Sleep Apnea Coordinated Care
A unique new care management solution will accelerate diagnosis and treatment of AFib and sleep apnea patients in cardiology practices NEW YORK, Nov. 3, 2021 /PRNewswire/ — Peerbridge Health and BetterNight are partnering on a unique new care management solution designed specifically for cardiology practices for earlier identification, treatment, and optimization of […]
VUNO Med®-DeepECG™ Designated as Breakthrough Device
SEOUL, South Korea, Nov. 2, 2021 /PRNewswire/ — South Korean artificial intelligence (AI) developer, VUNO inc. announced that the Korean Ministry of Food and Drug Safety (KFDA) has designated the company’s artificial intelligence-based electrocardiogram (ECG) analysis software VUNO Med®-DeepECG™ as the ministry’s 16th Breakthrough Device. Using deep learning, the software analyzes ECG data […]
IMPULSE DYNAMICS ANNOUNCES FIRST OPTIMIZER IMPLANT IN CHINA
Breakthrough CCM Therapy Now Being Implemented in China MARLTON, N.J., Nov. 01, 2021 (GLOBE NEWSWIRE) — Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart failure, today announced the first implantation of a patient in China with its innovative Optimizer system delivering CCM […]


